Results 111 to 120 of about 88,507,977 (198)

2′-Fucosyllactose promotes intestinal epithelial development via modulating gut microbial metabolism in neonatal 2′-Fucosyllactose promotes intestinal epithelial development via modulating gut microbial metabolism in neonatal mice

Journal of Dairy Science
: 2′-Fucosyllactose (2′-FL), a major human milk oligosaccharide, has been demonstrated to support early-life gut maturation and microbial balance. However, the association between 2′-FL, intestinal epithelial development, and gut microbiota remains ...
Lingling Guo, Renzhi Huang, Dayu Yang, Chuanlai Xu, Hua Kuang, Baimei Shi   +5 more
doaj   +1 more source

Validation of collection and anaerobic fermentation techniques for measuring prebiotic impact on gut microbiota

Pharmacological Research
Background: Defining the ability of prebiotic dietary carbohydrates to influence the composition and metabolism of the gut microbiota is central to defining their health impact in diverse individuals. Many clinical trials are using indirect methods. This
Alexander W. Thorman, Ardythe L. Morrow, Andre Groeneveld, Arjen Nauta, David S. Newburg   +4 more
doaj   +1 more source

Improved Simple Sample Pretreatment Method for Quantitation of Major Human Milk Oligosaccharides Using Ultrahigh Pressure Liquid Chromatography with Fluorescence Detection

, 2019
Human milk oligosaccharides (HMOs) maintain and promote infant health. Most of the current methods for HMOs quantitation require labor-intensive and time-consuming steps for sample preparation.
Xunwen Huang (7499177), Weicang Qiao (7499180), Tiemin Jiang, Chunying Yang, Hang Xiao, Lijun Chen, Weicang Qiao, Baoli Zhu (43136), Yanhui Han (422668), Tiemin Jiang (6700340), Hang Xiao (400864), Juncai Hou (7499183), Yanhui Han, Lijun Chen (313408), Baoli Zhu, Chunying Yang (645887), Xunwen Huang, Juncai Hou   +17 more
core   +1 more source

Assessment of 3-Fucosyllactose (3-FL) as a Novel Food for Use in Food and Food Supplements (RP2106)

FSA Research and Evidence
Chr. Hansen, Denmark (“the applicant”) submitted a novel food application for the authorisation of 3-fucosyllactose (3-FL) as a novel food to each nation of Great Britain in September 2023. The novel food is intended to be used as a source of human identical milk oligosaccharide, 3-FL, and is manufactured by ...
openaire   +1 more source

Safety Assessment of 3-Fucosyllactose (3-FL) as a Novel Food for Use in Food and Food Supplements (RP2001)

FSA Research and Evidence
The Food Standards Agency (FSA) and Food Standards Scotland (FSS) received an application from Inbiose N.V., Belgium (“the applicant”) for the authorisation of 3-fucosyllactose (3-FL) as a novel food in April 2023. The novel food is intended to be used as a source of the human identical milk oligosaccharide, 3-FL,
openaire   +1 more source

Safety Assessment on the Change to Conditions of Use of the Novel Food 3-Fucosyllactose (3-FL) Produced Using a Derivative Strain of Escherichia Coli BL21 (DE3) to Increase the Permitted Use Levels (RP2363)

The Food Standards Agency (FSA) and Food Standards Scotland (FSS) received an application in December 2025 from Chr. Hansen A/S, Denmark (“the applicant”) for the authorisation of a change of conditions of use for 3-fucosyllactose (3-
Food Standards Agency, Food Standards Scotland   +1 more
core   +1 more source

Correction: Precision synbiotic intervention with 2'-fucosyllactose and infant-derived <i>Bifidobacterium</i> modulates gut-immune axis and reduces disease risk in toddlers: a randomized controlled trial. [PDF]

Front Nutr
Chen K, Zhang X, Jin S, Zhong J, Chen H, Yue G, Cheng Y, Peng R, Fang Z, Liu F, Lu Z, Zhao L, Hu R, Tao X, He Q, Liu C.   +15 more
europepmc   +1 more source

2'-Fucosyllactose modulates gut microbiota and systemic metabolism in mild-to-moderate ulcerative colitis: a randomized crossover trial. [PDF]

J Crohns Colitis
Kennedy JM, De Silva AN, Morales PS, Poveda Turrado CG, Walton GE, Gibson GR.   +5 more
europepmc   +1 more source

Exploring the effect of tandem non-native non-F-type lectin carbohydrate-binding domains on <i>Streptosporangium roseum</i> α-L-Fucosidase activity. [PDF]

Biochem Biophys Rep
Shivangi, Lata M, Subramanian S, Ramya TNC.   +3 more
europepmc   +1 more source

Aryl Hydrocarbon Receptor Deficiency Impairs Intestinal Barrier Development, While 2'-Fucosyllactose Reduces Paracellular Permeability in Caco-2 Cells. [PDF]

Toxins (Basel)
Madella AM, van Gerven CCE, Sendino Garví E, van Bergenhenegouwen J, Garssen J, Masereeuw R, Overbeek SA.   +6 more
europepmc   +1 more source